Rx Product News Profile: A Closer Look at New FDA Actions: Novo Nordisk's Victoza
June 15th 2010Novo Nordisk's Victoza (liraglutide), the first glucagon-like peptide-1 receptor agonist subcutaneous injection, received FDA approval for the treatment of type 2 diabetes mellitus.
Pregnancy and Lactation Labeling
This article details what pharmacists need to know about the FDA's new proposed rule on pregnancy and lactation labeling.